Surface receptors and functional interactions of human natural killer cells: From bench to the clinic

Cellular and Molecular Life Sciences

Volumn 60, Issue 10, 2003, Pages 2139-2146

  Moretta, L ^a   Bottino, C ^b   Ferlazzo, G ^c   Pende, D ^c   Melioli, G ^b   Mingari, M C ^a,c   Moretta, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Dendritic cell; Hematopoietic transplantation; HLA class I allele; NK cell; NK receptor

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR7; HLA ANTIGEN CLASS 1; HLA E ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; CELL MATURATION; CELL SURFACE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HLA TYPING; HUMAN; NATURAL KILLER CELL; REVIEW; TUMOR CELL; VIRUS INFECTION;

DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, CELL SURFACE; STEM CELL TRANSPLANTATION;

ALPHAVIRUS;

EID: 0242383478     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3102-z     Document Type: Review

References (68)

1. Trinchieri G. (1989) Biology of natural killer cells. Adv. Immunol. 7: 176-187
2. Mingari M. C., Poggi A., Biassoni R., Bellomo R., Ciccone E., Pella N. et al. (1991) In vitro proliferation and cloning of CD3-CD16+ cells from human thymocyte precursors. J. Exp. Med. 174: 21-26
3. Rodewald H. R., Moingeon P., Lucich J. L., Dosiou C., Lopez P. and Reinherz E. L. (1992) A population of early fetal thymocytes expressing FcγRII/III contains precursors of T lymphocytes and natural killer cells. Cell 69: 139-149
4. Lanier L. L., Spits H. and Phillips J. H. (1992) The developmental relationship between NK cells and T cells. Immunol. Today 13: 392-399
5. Moretta L., Ciccone E., Mingari M. C., Biassoni R. and Moretta A. (1994) Human NK cells: origin, clonality, specificity and receptors. Adv. Immunol. 55: 341-380
6. Mingari M. C., Vitale C., Cantoni C., Bellomo R., Ponte M., Schiavetti F. et al. (1997) Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2 A as the only HL class I specific inhibitory receptor. Eur. J. Immunol. 27: 1374-1380
7. Ljunggren H. G. and Kärre K. (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11: 237-244
8. Yokoyama W. M. and Seaman W. E. (1993) The Ly49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11: 613-635
9. Moretta A., Bottino C., Vitale M., Pende, D., Biassoni, R., Mingari M. C. et al. (1996) Receptors for HL class I-molecules in human natural killer cells. Annu. Rev. Immunol. 14: 619-648
10. Lanier L. L. (1998) NK cell receptors. Annu. Rev. Immunol. 16: 359-393
11. Long E. O. (1999) Regulation of immune response through inhibitory receptors. Annu. Rev. Immunol. 17: 875-904
12. Lopez-Botet M., Pérez Villar M., Carretero M., Rodriguez, I., Melero, I., Bellon, T. et al. (1997) Structure and function of the CD94 C-type lectin receptor complex involved in the recognition of HLA class I molecules. Immunol. Rev. 155: 165-174
13. Moretta A., Sivori S., Vitale M., Pende D., Morelli L., Augugliaro R. et al. (1995) Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182: 875-884
14. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M. et al. (1996) The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183: 645-650
15. Bottino C., Sivori S., Vitale M., Cantoni C., Falco M., Pende D. et al. (1996) A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur. J. Immunol. 26: 1816-1824
16. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M. C. et al. (2001) Activating receptors and coreceptors involved in the natural cytotoxicity. Annu. Rev. Immunol. 19: 197-223
17. Moretta A., Biassoni R., Bottino C., Mingari M. C. and Moretta L. (2000) Natural cytotoxicity receptors that trigger the human NK-mediated cytolysis. Immunol. Today 21: 228-234
18. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C. et al. (1997) p46, a novel natural killer cell-specific surface molecule which mediates cell activation. J. Exp. Med. 186: 1129-1136
19. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L. et al. (1998) Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188: 953-960
20. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L. et al. (1999) Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190: 1505-1516
21. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E. et al. (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis. J. Exp. Med. 187: 2065-2072
22. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A. et al. (1999) NKp44, a triggering receptor involved in tumor cell lsysis by activated human Natural Killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 189: 787-796
23. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R. et al. (1999) NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh cultured human NK cells: correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29: 1656-1666
24. Biassoni R., Pessino A., Bottino C., Pende D., Moretta L. and Moretta A. (1999) The murine homologoue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 29: 1014-1020
25. Bauer S., Groh V., Wu J., Steinle A., Phillips J. H., Lanier L. L. et al. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729
26. Pende D., Cantoni C., Rivera P., Vitale M., Castriconi R., Marcenaro S. et al. (2001) Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and cap ility of recognizing tumors of non epithelial origin. Eur. J. Immunol. 31: 1076-1086
27. Cosman D., Mullberg J., Sutherland C. L., Chin W., Armitage R., Fanslow W. et al. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133
28. Pende D., Rivera P., Marcenaro S., Chang C. C., Biassoni R., Conte R. et al. (2002) Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 62: 6178-6186
29. Sivori S., Parolini S., Falco M., Marcenaro E., Biassoni R., Bottino C. et al. (2000) 2B4 functions as a co-receptor in human natural killer cell activation. Eur. J. Immunol. 30: 787-793
30. Vitale M., Falco M., Castriconi R., Parolini S., Zambello G., Semenzato R. et al. (2001) Identification of NKp80, a novel triggering molecule expressed by human natural killer cells. Eur. J. Immunol. 31: 233-242
31. Parolini S., Bottino C., Falco M., Augugliaro R., Giuliani S., Franceschini R. et al. (2000) X-linked lymphoproliferative disease: 2 B4 molecules displaying inhibitory rather than activating function are responsible for the in ility of NK cell to kill EBV-infected cells. J. Exp. Med. 192: 337-346
32. Tangye S. G., Phillips J. H., Lanier L. L. and Nichols K. E. (2000) Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165: 2932-2936
33. Bottino C., Falco M., Parolini S., Marcenaro E., Augugliaro R., Sivori S. et al. (2001) NTB-A, a novel SH2D1 A-associated surface molecule contributing to the in ility of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194: 235-246
34. Khakoo S. I., Rajalingam R., Shum B. P., Weidenbach K., Flodin L., Muir D. G. et al. (2000) Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 12: 687-698
35. Ferlazzo G., Tsang M. L., Moretta L., Melioli G., Steinman R. M. and Munz C. (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-351
36. Banchereau J. and Steinman R. M. (1998) Dendritic cells and the control of immunity. Nature 392: 245-252
37. Thery C. and Amigorena S. (2001) The cell biology of antigen presentation in dendritic cells. Curr. Opin. Immunol. 13: 45-51
38. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y. J. et al. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811
39. Sallusto F., Cella M., Danieli C. and Lanzavecchia A. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182: 389-400
40. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I. et al. (1999) Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29: 1617-1625
41. Sallusto F., Mackay C. R. and Lanzavecchia A. (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18: 593-620
42. Fernandez N. C., Lozier, A., Flament, C., Ricciardi-Castagnoli P., Bellet D., Suter M. et al. (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Med. 5: 405-411
43. Geldhof A. B., Moser M., Lespagnard L., Thielemans K. and De Baetselier P. (1998) Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood 91: 196-206
44. Wilson J. L., Charo J., Martin-Fontecha A., Dellabona P., Casorati G., Chambers B. J. et al. (1999) NK cell triggering by the human costimulatory molecules CD80 and CD86. J. Immunol. 163: 4207-4212
45. Wilson J. L., Heffler L. C., Charo J., Scheynius A., Bejarano M.T. and Ljunggren H.G. (1999) Targeting of human dendritic cells by autologous NK cells. J. Immunol. 163: 6365-6370
46. Ferlazzo G., Semino C. and Melioli G. (2001) HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol. Lett. 76: 37-41
47. Ferlazzo G., Morandi B., D'Agostino A., Meazza R., Melioli G., Moretta A. et al. (2003) The interaction between natural killer and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 33: 306-313
48. Inaba K., Inaba M., Naito M. and Steinman R. M. (1993) Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178: 479-488
49. Moretta A. (2002) Natural killer and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2: 1-8
50. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G. and Trinchieri G. (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333
51. Granucci F., Vizzardelli C., Pavelka N., Feau S., Persico M., Virzi E. et al. (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2: 882-888
52. Mattei F., Schiavoni G., Belardelli F. and Tough D. F. (2001) IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167: 1179-1187
53. Brandau S., Riemensberger J., Jacobsen M., Kemp D., Zhao W., Zhao X. et al. (2001) NK cells are essential for effective BCG immunotherapy. Int. J. Cancer 92: 697-702
54. Morelli A. E., Zahorchak A. F., Larregina A. T., Colvin B. L., Logar A. J., Takayama T. et al. (2001) Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 98: 1512-1523
55. Kalinski P., Hilkens C. M., Wierenga E. A. and Kapsenberg M. L. (1999) T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20: 561-567
56. Jonuleit H., Schmitt E., Schuler G., Knop J. and Enk A. H. (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222
57. Dhodapkar M. V., Steinman R. M., Krasovsky J., Munz C. and Bhardwaj N. (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193: 233-238
58. Steinman R. M., Hawiger D. and Nussenzweig M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711
59. Liu Y. J., Kanzler H., Soumelis V. and Gilliet M. (2001) Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2: 585-589
60. Ujike A., Takeda K., Nakamura A., Ebihara S., Akiyama K. and Takai T. (2002) Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. Nat. Immunol. 3: 542-548
61. Maggi E., Parronchi P., Manetti R., Simonelli C., Piccinni M. P., Rugiu F. S. et al. (1992) Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 48: 2142-2147
62. Bradley L. M., Dalton D. K. and Croft M. (1996) A direct role for IFN-gamma in regulation of Th1 cell development. J. Immunol. 157: 1350-1358
63. Hayes M. P., Wang J. and Norcross M. A. (1995) Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood 86: 646-650
64. Szabo S. J., Dighe A. S., Gubler U. and Murphy K. M. (1997) Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185: 817-824
65. Coudert J. D., Coureau C. and Guery J. C. (2002) Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 response to transplantation antigens. J. Immunol. 169: 2979-2987
66. Velardi A., Ruggeri L., Moretta A. and Moretta L. (2002) NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol. 23: 438-444
67. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W. D., Tosti S. et al. (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 2097-2100
68. Kärre K. (2002) A perfect mismatch. Science 295: 2029-2031